Moving toward improved influenza vaccines

Journal of Infectious Diseases

Volumn 215, Issue 4, 2017, Pages 500-502

  Monto, Arnold S ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE; IMMUNOLOGICAL ADJUVANT;

DRUG MEGADOSE; EDITORIAL; FRAILTY; HUMAN; INFLUENZA; INFLUENZA VACCINATION; INTERNATIONAL CLASSIFICATION OF DISEASES; MEDICARE; MORTALITY; SOCIAL STATUS; IMMUNOLOGY; UNITED STATES;

ADJUVANTS, IMMUNOLOGIC; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MEDICARE; UNITED STATES;

EID: 85017019086     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiw644     Document Type: Editorial

References (28)

1. Salk JE, Menke WJ, Francis T. A clinical, epidemiological and immunological evaluation of vaccination against epidemic influenza. Am J Epidemiol 1945; 42:57-93.
2. Davenport FM. Protective efficacy of inactivated influenza vaccines, 1943-1969. Med J Aust 1973; 33-8.
3. Petrie JG, Ohmit SE, Johnson E, Cross RT, Monto AS. Efficacy studies of influenza vaccines: effect of end points used and characteristics of vaccine failures. J Infect Dis 2011; 203:1309-15.
4. Langmuir AD, Henderson DA, Serfling RE. The epidemiological basis for the control of influenza. Am J Public Health Nations Health 1964; 54:563-71.
5. Strassburg MA, Greenland S, Sorvillo FJ, Lieb LE, Habel LA. Influenza in the elderly: report of an outbreak and a review of vaccine effectiveness reports. Vaccine 1986; 4:38-44.
6. Beyer WE, Palache AM, Baljet M, Masurel N. Antibody in duction by influenza vaccines in the elderly: a review of the literature. Vaccine 1989; 7:385-94.
7. Gross PA, Hermogenes AW, Sacks HS, Lau J, Levandowski RA. The efficacy of influenza vaccine in elderly persons. A meta-analysis and review of the literature. Ann Intern Med 1995; 123:518-27.
8. Ohmit SE, Victor JC, Rotthoff JR, et al. Prevention of antigenically drifted influenza by inactivated and live attenuated vaccines. N Engl J Med 2006; 355:2513-22.
9. Monto AS, Ohmit SE, Petrie JG, et al. Comparative efficacy of inactivated and live attenuated influenza vaccines. N Engl J Med 2009; 361:1260-7.
10. Osterholm MT, Kelley NS, Sommer A, Belongia EA. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect Dis 2012; 12:36-44.
11. Orenstein EW, De Serres G, Haber MJ, et al. Methodologic issues regarding the use of three observational study designs to assess influenza vaccine effectiveness. Int J Epidemiol 2007; 36:623-31.
12. Ohmit SE, Thompson MG, Petrie JG, et al. Influenza vaccine effectiveness in the 2011-2012 season: protection against each circulating virus and the effect of prior vaccination on estimates. Clin Infect Dis 2014; 58:319-27.
13. Skowronski DM, Chambers C, Sabaiduc S, et al. A perfect storm: impact of genomic variation and serial vaccination on low influenza vaccine effectiveness during the 2014-2015 season. Clin Infect Dis 2016; 63:21-32.
14. McLean HQ, Thompson MG, Sundaram ME, et al. Influenza vaccine effectiveness in the united states during 2012-2013: variable protection by age and virus type. J Infect Dis 2015; 211:1529-40.
15. Davenport FM, Hennessy AV, Bell JA. Immunologic advantages of emulsified influenza virus vaccines. Mil Med 1962; 127:95-100.
16. Ujhazy V. Clinical trials of oil-adjuvant influenza vaccines, 1960-3. Report to the medical research council by its committee on influenza and other respiratory virus vaccines. Br Med J 1964; 2:267-71.
17. Weibel RE, McLean A, Woodhour AF, Friedman A, Hilleman MR. Ten-year follow-up study for safety of adjuvant 65 influenza vaccine in man. Proc Soc Exp Biol Med 1973; 143:1053-6.
18. Keitel WA, Couch RB, Cate TR, et al. High doses of purified influenza A virus hemagglutinin significantly augment serum and nasal secretion antibody responses in healthy young adults. J Clin Microbiol 1994; 32:2468-73.
19. Keitel WA, Cate TR, Atmar RL, et al. Increasing doses of purified influenza virus hemagglutinin and subvirion vaccines enhance antibody responses in the elderly. Clin Diagn Lab Immunol 1996; 3:507-10.
20. Falsey AR, Treanor JJ, Tornieporth N, Capellan J, Gorse GJ. Randomized, double-blind controlled phase 3 trial comparing the immunogenicity of high-dose and standard-dose influenza vaccine in adults 65 years of age and older. J Infect Dis 2009; 200:172-80.
21. DiazGranados CA, Dunning AJ, Kimmel M, et al. Efficacy of high-dose versus standard-dose influenza vaccine in older adults. N Engl J Med 2014; 371:635-45.
22. DiazGranados CA, Robertson CA, Talbot HK, Landolfi V, Dunning AJ, Greenberg DP. Prevention of serious events in adults 65 years of age or older: a comparison between high-dose and standard-dose inactivated influenza vaccines. Vaccine 2015; 33:4988-93.
23. DiazGranados CA, Dunning AJ, Robertson CA, Talbot HK, Landolfi V, Greenberg DP. Effect of previous-year vaccination on the efficacy, immunogenicity, and safety of high-dose inactivated influenza vaccine in older adults. Clin Infect Dis 2016; 62:1092-9.
24. Shay DK, Chillarige Y, Kelman J, et al. Comparative effectiveness of high-dose versus standard-dose influenza vaccines among us medicare beneficiaries in preventing post-influenza deaths during 2012-13 and 2013-14 -manuscript draft-.
25. Izurieta HS, Thadani N, Shay DK, et al. Comparative effectiveness of high-dose versus standard-dose influenza vaccines in us residents aged 65 years and older from 2012 to 2013 using medicare data: a retrospective cohort analysis. Lancet Infect Dis 2015; 15:293-300.
26. Gaglani M, Pruszynski J, Murthy K, et al. Influenza vaccine effectiveness against 2009 pandemic influenza A(H1N1) virus differed by vaccine type during 2013-2014 in the United States. J Infect Dis 2016; 213:1546-56.
27. FLUAD [US package insert]. Holly Springs NC: Seqirus Inc. March 2016. http://www.fda.gov/downloads/BiologicsBloodVaccines/SafetyAvailability/VaccineSafety/UCM474387.pdf. Accessed 21 December 2016.
28. Mannino S, Villa M, Apolone G, et al. Effectiveness of adjuvanted influenza vaccination in elderly subjects in northern Italy. Am J Epidemiol 2012; 176:527-33.